Hub : Traits :

Heart attack/myocardial infarction (self-reported)

48 significantly associated models · 15 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	109098737	110517617	3	1	5.4e-09	3.9e-09	1.0e+00	100	PSRC1
2	1	222096959	223567803	3	1	2.4e-12	3.5e-12	1.0e+00	100	RP11-378J18.8
3	3	135861666	137253713	1	1	2.8e-07	1.1e-07	8.0e-02	89	RP11-731C17.2
4	6	12020241	13990267	2	1	1.1e-16	1.0e-16	3.8e-02	94	RP1-257A7.5
5	6	159820779	161571560	2	2	5.3e-09	4.8e-12	1.3e-08	32	RP11-288H12.3 SLC22A3
6	9	21303958	22819407	2	2	7.3e-16	6.8e-31	8.3e-16	52	CDKN2B CDKN2B-AS1
7	15	90730363	92135418	1	1	3.6e-08	2.8e-06	5.6e-01	98	FES

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
LDL Cholesterol	64.06	2	1	2.2	0.00	1.0e+00	PSRC1 RP11-288H12.3
Heart attack	33.67	9	8	17.8	1.00	2.2e-13	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-378J18.8 RP11-731C17.2 RP1-257A7.5 SLC22A3
Coronary Artery Disease (CAD)	31.53	5	4	8.9	0.99	1.6e-03	CDKN2B CDKN2B-AS1 PSRC1 RP1-257A7.5 SLC22A3
Illnesses of father: Heart disease	31.50	9	6	13.3	0.96	3.1e-05	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-378J18.8 RP11-731C17.2 RP1-257A7.5 SLC22A3
Angina (self-reported)	31.15	8	5	11.1	0.96	1.2e-04	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-378J18.8 RP1-257A7.5 SLC22A3
High cholesterol (Self-reported)	30.66	6	3	6.7	0.79	6.3e-02	FES PSRC1 RP11-288H12.3 RP11-378J18.8 RP11-731C17.2 SLC22A3
Angina	30.02	8	5	11.1	0.96	1.5e-04	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-378J18.8 RP1-257A7.5 SLC22A3
Medication: Cholesterol lowering	29.70	8	3	6.7	0.88	3.7e-03	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-378J18.8 RP11-731C17.2 SLC22A3
Medication: Atorvastatin	20.51	5	2	4.4	0.99	1.4e-03	CDKN2B CDKN2B-AS1 PSRC1 RP11-288H12.3 SLC22A3
Medication: Simvastatin	20.02	6	2	4.4	0.94	4.9e-03	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-731C17.2 SLC22A3
Medication: Aspirin	18.20	7	5	11.1	0.99	4.4e-06	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-731C17.2 SLC22A3
Medication: Aspirin	17.94	7	5	11.1	0.99	5.9e-06	CDKN2B CDKN2B-AS1 FES PSRC1 RP11-288H12.3 RP11-731C17.2 SLC22A3
Cholesterol lowering medication	17.36	5	2	4.4	0.95	1.2e-02	CDKN2B PSRC1 RP11-288H12.3 RP11-731C17.2 SLC22A3
Heart disease (mother)	14.77	7	2	4.4	0.98	1.2e-04	CDKN2B CDKN2B-AS1 FES RP11-288H12.3 RP11-378J18.8 RP1-257A7.5 SLC22A3
Medication for cholesterol, blood pressure or diabetes	13.87	4	2	4.4	-0.85	1.5e-01	FES PSRC1 RP11-378J18.8 RP11-731C17.2
Illnesses of father: None of the above (group 1)	12.38	5	2	4.4	-0.99	6.0e-04	CDKN2B CDKN2B-AS1 FES RP11-731C17.2 SLC22A3
Heart disease (siblings)	12.11	6	0	0.0	0.97	1.1e-03	CDKN2B-AS1 FES PSRC1 RP11-378J18.8 RP1-257A7.5 SLC22A3
Cardiovascular Disease	11.84	5	3	6.7	0.98	2.3e-03	FES PSRC1 RP11-288H12.3 RP11-731C17.2 SLC22A3
Vascular/heart problems diagnosed by doctor	10.48	4	1	2.2	-0.96	3.9e-02	CDKN2B FES RP11-731C17.2 SLC22A3
Eye problems/disorders: Glaucoma	9.22	2	2	4.4	0.00	1.0e+00	CDKN2B CDKN2B-AS1
High blood pressure (mother)	9.10	2	1	2.2	0.00	1.0e+00	FES RP1-257A7.5
Hypertension (Self-reported)	8.84	4	1	2.2	0.43	5.7e-01	FES RP11-731C17.2 RP1-257A7.5 SLC22A3
High blood pressure	8.55	3	1	2.2	0.00	1.0e+00	FES RP11-731C17.2 RP1-257A7.5
Father's age at death	8.08	4	1	2.2	-1.00	3.1e-03	CDKN2B CDKN2B-AS1 FES PSRC1
Systolic Blood Pressure	7.78	3	2	4.4	0.00	1.0e+00	FES RP1-257A7.5 SLC22A3
Medication: Atenolol	7.61	2	1	2.2	0.00	1.0e+00	CDKN2B FES
Medication for cholesterol	7.49	3	1	2.2	0.00	1.0e+00	FES PSRC1 SLC22A3
Glaucoma (self-reported)	7.26	2	1	2.2	0.00	1.0e+00	CDKN2B CDKN2B-AS1
Medication: Blood pressure	7.13	1	1	2.2	0.00	1.0e+00	FES
Medication: Blood pressure	7.13	2	1	2.2	0.00	1.0e+00	FES SLC22A3
Systolic blood pressure, automated reading	6.97	2	2	4.4	0.00	1.0e+00	FES RP1-257A7.5
Illnesses of mother	6.65	2	1	2.2	0.00	1.0e+00	CDKN2B FES
Diastolic blood pressure, automated reading	6.22	3	1	2.2	0.00	1.0e+00	CDKN2B CDKN2B-AS1 FES
Medication: Ibuprofen (e.g. Nurofen)	5.93	3	1	2.2	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Medication: Ramipril	5.92	1	0	0.0	0.00	1.0e+00	FES
Illnesses of father: High blood pressure	5.90	1	1	2.2	0.00	1.0e+00	FES
Headache pain in last month	5.79	2	1	2.2	0.00	1.0e+00	FES RP1-257A7.5
Medication: Ibuprofen	5.79	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Migraine (self-reported)	5.75	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Pulse wave peak to peak time	4.99	2	0	0.0	0.00	1.0e+00	FES RP1-257A7.5
Pulse wave Arterial Stiffness index	4.96	2	0	0.0	0.00	1.0e+00	FES RP1-257A7.5
Birth weight of first child	4.86	1	1	2.2	0.00	1.0e+00	FES
Number of treatments/medications taken	4.62	3	0	0.0	0.00	1.0e+00	FES PSRC1 RP11-731C17.2
Schizophrenia (2018)	4.38	2	1	2.2	0.00	1.0e+00	FES RP11-731C17.2
Schizophrenia (2014)	4.26	2	1	2.2	0.00	1.0e+00	FES RP11-731C17.2
Medication for pain relief, constipation, heartburn	4.19	3	0	0.0	0.00	1.0e+00	PSRC1 RP11-731C17.2 RP1-257A7.5
Bipolar Disorder or Schizophrenia	4.18	2	1	2.2	0.00	1.0e+00	FES RP11-731C17.2
Illnesses of siblings	3.99	1	1	2.2	0.00	1.0e+00	FES
HDL Cholesterol	3.88	2	1	2.2	0.00	1.0e+00	PSRC1 RP11-731C17.2
High blood pressure (siblings)	3.82	1	1	2.2	0.00	1.0e+00	FES
Risk taking	3.77	2	0	0.0	0.00	1.0e+00	FES RP11-731C17.2
Chest pain or discomfort	3.55	1	0	0.0	0.00	1.0e+00	CDKN2B
Medication: Amlodipine	3.47	1	1	2.2	0.00	1.0e+00	FES
Triglycerides	3.37	2	0	0.0	0.00	1.0e+00	RP11-288H12.3 RP11-731C17.2
Medication: Bendroflumethiazide	3.32	1	1	2.2	0.00	1.0e+00	FES
Type 2 Diabetes (T2D) (2012)	3.29	1	0	0.0	0.00	1.0e+00	CDKN2B
Breast Cancer	3.13	3	0	0.0	0.00	1.0e+00	CDKN2B CDKN2B-AS1 FES
Number of self-reported non-cancer illnesses	3.12	1	0	0.0	0.00	1.0e+00	PSRC1
Basal cell carcinoma (self-reported)	3.08	1	0	0.0	0.00	1.0e+00	CDKN2B
Medication: Paracetamol	3.06	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Supplements: Fish oil (including cod liver oil)	3.01	1	0	0.0	0.00	1.0e+00	SLC22A3
Birth weight	3.00	1	1	2.2	0.00	1.0e+00	FES
Waist Hip Ratio (WHR)	2.91	4	1	2.2	0.91	8.7e-02	RP11-288H12.3 RP11-378J18.8 RP11-731C17.2 SLC22A3
Past tobacco smoking	2.82	1	0	0.0	0.00	1.0e+00	CDKN2B-AS1
Mineral and other dietary supplements	2.74	1	0	0.0	0.00	1.0e+00	FES
Smoking status: Previous	2.63	1	0	0.0	0.00	1.0e+00	CDKN2B-AS1
Noisy workplace	2.60	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Breast cancer (self-reported)	2.54	1	0	0.0	0.00	1.0e+00	CDKN2B
Type 2 Diabetes (T2D) (2018)	2.53	2	0	0.0	0.00	1.0e+00	RP11-731C17.2 SLC22A3
Long-standing illness, disability or infirmity	2.51	1	0	0.0	0.00	1.0e+00	CDKN2B
Neck or shoulder pain in last month	2.49	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Medication: Paracetamol	2.47	2	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5
Medication: Metformin	2.40	1	0	0.0	0.00	1.0e+00	CDKN2B
Medication: Lisinopril	2.38	1	0	0.0	0.00	1.0e+00	FES
BMI	2.36	3	1	2.2	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Falls in the last year	2.35	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Leg fat percentage (right)	2.35	2	1	2.2	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5
Sensitivity / hurt feelings	2.31	1	1	2.2	0.00	1.0e+00	FES
Hand grip strength (left)	2.27	2	0	0.0	0.00	1.0e+00	FES RP1-257A7.5
Number of incorrect matches in round	2.27	1	0	0.0	0.00	1.0e+00	FES
Smoking Status	2.19	1	0	0.0	0.00	1.0e+00	FES
Impedance of arm (right)	2.19	2	1	2.2	0.00	1.0e+00	CDKN2B RP11-731C17.2
Relative age of first facial hair	2.17	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Ever smoked	2.15	1	0	0.0	0.00	1.0e+00	FES
Alcohol intake frequency.	2.08	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Hearing difficulty/problems: Yes	2.06	1	0	0.0	0.00	1.0e+00	RP11-378J18.8
Impedance of leg (right)	2.06	3	1	2.2	0.00	1.0e+00	FES RP11-378J18.8 RP11-731C17.2
Hip circumference	2.06	2	1	2.2	0.00	1.0e+00	RP11-731C17.2 SLC22A3
Waist circumference	2.04	2	1	2.2	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5
Mean time to correctly identify matches	2.04	1	0	0.0	0.00	1.0e+00	FES
Relative age voice broke	2.03	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Alcohol usually taken with meals	2.03	1	0	0.0	0.00	1.0e+00	FES
Leg fat percentage (left)	2.02	2	1	2.2	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5
Impedance of leg (left)	1.98	3	1	2.2	0.00	1.0e+00	FES RP11-378J18.8 RP11-731C17.2
Blood White Count	1.96	4	2	4.4	0.54	4.6e-01	CDKN2B FES RP11-731C17.2 RP1-257A7.5
Breastfed as a baby	1.96	1	0	0.0	0.00	1.0e+00	FES
Whole body fat mass	1.91	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Leg fat mass (right)	1.91	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Diabetes diagnosed by doctor	1.90	1	0	0.0	0.00	1.0e+00	SLC22A3
Arm fat percentage (right)	1.88	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Respiratory disease	1.87	1	0	0.0	0.00	1.0e+00	FES
Pain experienced in last month	1.87	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Hand grip strength (right)	1.85	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Arm fat percentage (left)	1.85	2	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5
Arm fat mass (left)	1.85	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Body mass index (BMI)	1.84	2	1	2.2	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5
Arm fat mass (right)	1.84	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Body fat percentage	1.83	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Impedance of whole body	1.82	2	1	2.2	0.00	1.0e+00	PSRC1 RP11-731C17.2
Bipolar Disorder (2018)	1.81	1	0	0.0	0.00	1.0e+00	FES
Trunk fat mass	1.80	2	0	0.0	0.00	1.0e+00	RP1-257A7.5 SLC22A3
Pulse rate, automated reading	1.75	2	0	0.0	0.00	1.0e+00	RP11-378J18.8 RP1-257A7.5
Leg fat mass (left)	1.73	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Handedness (chirality/laterality): Left-handed	1.72	1	0	0.0	0.00	1.0e+00	FES
Trunk fat percentage	1.69	2	0	0.0	0.00	1.0e+00	RP1-257A7.5 SLC22A3
Nervous feelings	1.63	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Impedance of arm (left)	1.63	1	1	2.2	0.00	1.0e+00	RP11-731C17.2
Weight	1.62	3	0	0.0	0.00	1.0e+00	RP11-731C17.2 RP1-257A7.5 SLC22A3
Age started oral contraceptive pill	1.62	1	0	0.0	0.00	1.0e+00	FES
Leg predicted mass (right)	1.60	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Allergy	1.59	1	0	0.0	0.00	1.0e+00	FES
Leg fat-free mass (right)	1.59	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Leg fat-free mass (left)	1.57	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Leg predicted mass (left)	1.57	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Lung FEV1/FVC ratio	1.55	2	2	4.4	0.00	1.0e+00	PSRC1 RP11-378J18.8
Hayfever, allergic rhinitis or eczema	1.54	1	0	0.0	0.00	1.0e+00	FES
Allergy or Eczema	1.53	1	0	0.0	0.00	1.0e+00	FES
Hair/balding pattern: Pattern 4	1.53	1	0	0.0	0.00	1.0e+00	FES
Basal metabolic rate	1.47	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Height	1.45	5	5	11.1	-0.98	3.5e-03	FES PSRC1 RP11-288H12.3 RP11-731C17.2 SLC22A3
Standing height	1.44	4	2	4.4	-0.98	1.6e-02	PSRC1 RP11-288H12.3 RP11-731C17.2 SLC22A3
Asthma (self-reported)	1.44	1	0	0.0	0.00	1.0e+00	FES
Whole body fat-free mass	1.43	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Average weekly champagne plus white wine intake	1.42	1	0	0.0	0.00	1.0e+00	RP11-288H12.3
Arm predicted mass (right)	1.41	3	0	0.0	0.00	1.0e+00	PSRC1 RP11-731C17.2 SLC22A3
Knee pain experienced in last month	1.41	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Asthma	1.39	1	0	0.0	0.00	1.0e+00	FES
Whole body water mass	1.39	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Comparative height size at age 10	1.37	3	0	0.0	0.00	1.0e+00	FES PSRC1 SLC22A3
Trunk fat-free mass	1.36	2	1	2.2	0.00	1.0e+00	PSRC1 SLC22A3
Wheeze or whistling in the chest in last year	1.35	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Trunk predicted mass	1.34	2	1	2.2	0.00	1.0e+00	PSRC1 SLC22A3
Arm fat-free mass (right)	1.34	3	0	0.0	0.00	1.0e+00	PSRC1 RP11-731C17.2 SLC22A3
Arm predicted mass (left)	1.31	2	0	0.0	0.00	1.0e+00	PSRC1 SLC22A3
Worry (Nagel 2018)	1.30	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Neuroticism (Nagel 2018)	1.21	1	0	0.0	0.00	1.0e+00	FES
Arm fat-free mass (left)	1.20	2	0	0.0	0.00	1.0e+00	PSRC1 SLC22A3
Blood Platelet Count	1.16	3	1	2.2	0.00	1.0e+00	CDKN2B RP11-731C17.2 SLC22A3
Number of live births	1.11	1	0	0.0	0.00	1.0e+00	FES
Qualifications: College or University degree	1.01	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Sitting height	0.86	2	0	0.0	0.00	1.0e+00	FES SLC22A3
Lung FVC	0.79	1	0	0.0	0.00	1.0e+00	RP11-378J18.8
Blood Red Count	0.65	2	0	0.0	0.00	1.0e+00	FES RP1-257A7.5
Hair Pigment	0.60	3	3	6.7	0.00	1.0e+00	CDKN2B CDKN2B-AS1 FES
Blood Eosinophil Count	0.59	1	0	0.0	0.00	1.0e+00	RP11-731C17.2
Heel T-Score	0.59	1	0	0.0	0.00	1.0e+00	PSRC1

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Artery Aorta	3	0.101	1.4
GTEx	Artery Coronary	1	0.085	1.4
GTEx	Artery Tibial	4	0.106	1.4
GTEx	Brain Cerebellum	1	0.050	1.4
GTEx	Brain Putamen basal ganglia	0	0.000	1.4
GTEx	Lung	1	0.035	1.4
GTEx	Spleen	0	0.000	1.4
GTEx	Stomach	0	0.000	1.4
GTEx	Vagina	0	0.000	1.4
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	1.4
GTEx	Adipose Subcutaneous	1	0.029	1.3
GTEx	Adipose Visceral Omentum	0	0.000	1.3
GTEx	Adrenal Gland	0	0.000	1.3
GTEx	Brain Caudate basal ganglia	0	0.000	1.3
GTEx	Brain Cerebellar Hemisphere	3	0.201	1.3
GTEx	Brain Cortex	0	0.000	1.3
GTEx	Brain Frontal Cortex BA9	0	0.000	1.3
GTEx	Brain Hypothalamus	1	0.169	1.3
GTEx	Breast Mammary Tissue	1	0.051	1.3
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.3
GTEx	Cells EBV-transformed lymphocytes	0	0.000	1.3
GTEx	Cells Transformed fibroblasts	3	0.071	1.3
GTEx	Colon Sigmoid	1	0.068	1.3
GTEx	Colon Transverse	0	0.000	1.3
GTEx	Esophagus Gastroesophageal Junction	1	0.069	1.3
GTEx	Esophagus Mucosa	1	0.030	1.3
GTEx	Esophagus Muscularis	2	0.062	1.3
GTEx	Heart Atrial Appendage	0	0.000	1.3
GTEx	Heart Left Ventricle	0	0.000	1.3
GTEx	Liver	1	0.139	1.3
GTEx	Muscle Skeletal	1	0.035	1.3
GTEx	Nerve Tibial	2	0.046	1.3
GTEx	Ovary	1	0.110	1.3
GTEx	Pancreas	0	0.000	1.3
GTEx	Pituitary	0	0.000	1.3
GTEx	Prostate	1	0.120	1.3
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.3
GTEx	Skin Sun Exposed Lower leg	2	0.055	1.3
GTEx	Small Intestine Terminal Ileum	0	0.000	1.3
GTEx	Thyroid	0	0.000	1.3
GTEx	Uterus	0	0.000	1.3
GTEx	Whole Blood	1	0.050	1.3
METSIM	Adipose	0	0.000	1.3
NTR	Blood	0	0.000	1.3
ROSMAP	Brain Pre-frontal Cortex	1	0.023	1.3
CommonMind	Brain Pre-frontal Cortex	4	0.074	1.3
The Cancer Genome Atlas	Breast Invasive Carcinoma	2	0.045	1.3
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	1	0.024	1.3
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	1	0.049	1.3
The Cancer Genome Atlas	Brain Lower Grade Glioma	2	0.046	1.3
The Cancer Genome Atlas	Lung Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Prostate Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.3
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Thyroid Carcinoma	1	0.019	1.3
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.2
GTEx	Breast Mammary Tissue (Female)	1	0.061	1.2
GTEx	Testis	0	0.000	1.2
YFS	Blood	0	0.000	1.2
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	0	0.000	1.2
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.2
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.2
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.2
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	2	0.181	1.2
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	0	0.000	1.2
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.2
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.2
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.2
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.2
GTEx	Brain Hippocampus	0	0.000	1.1